Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2009 Dec 1.

Published in final edited form as: Bioorg Med Chem. 2008 Oct 14;16(23):10022–10028. doi: 10.1016/j.bmc.2008.10.024

Table 1.

NMR Data for Compounds 1, 4–5 (CD₃OD).

	1			4			5

Pos.	δ_C	δ_H		δ_C	δ_H		δ_C	δ_H
1	133.94			132.67	8.34	d, 8.0, 1H	119.27	7.82	d, 8.4, 1H
2	131.54			133.32	7.99	t, 7.7, 1H	136.45	7.76	t, 7.5, 1H
3	150.18			131.39	7.90	t, 7.7, 1H	125.04	7.38	t, 7.5, 1H
4	151.58			124.93	8.80	d, 7.5, 1H	126.16	8.20	d, 8.4, 1H
4a				123.10			116.19
4b				139.08			150.76
5	115.37	7.00	s, 1H	122.01	8.90	d, 5.0, 1H	105.08	7.45	d, 6.6, 1H
6	136.52			150.89	9.14	d, 4.4, 1H	143.95	8.13	d, 6.6, 1H
7	32.06	3.30	m, 1H
		3.32	m, 1H
7a				147.71			124.67
8	59.56	3.29	m, 2H	181.05			136.60
9				144.73			139.78
10	57.02	3.96	s, 3H	150.21			108.43
10a				150.72			133.79
10b				118.76			120.40
11a				147.07			141.86
12	43.58	2.98	s, 6H	29.09	3.89	t, 7.4, 2H	29.30	3.29^*	m, 2H
13				40.17	3.37	t, 7.2, 2H	38.07	3.24	m, 2H
14				17.87	2.68	s, 3H	78.88	6.11	s, 2H

^*

Signal overlapped with CD₂HOD peak; detected by HSQC analysis